Navigation Links
FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohn's Disease
Date:11/8/2012

PRINCETON, N.J., Nov. 8, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA). Soligenix has also previously received Orphan Drug Designation from the FDA for oral BDP as a treatment for pediatric Crohn's Disease.

Fast track is a designation that the FDA reserves for a drug intended to treat a serious or life- threatening condition and one that demonstrates the potential to address an unmet medical need for the condition. Fast track designation is designed to facilitate the development and expedite the review of new drugs. For instance, should events warrant, Soligenix will be eligible to submit a new drug application (NDA) for SGX203 on a rolling basis, permitting the FDA to review sections of the NDA prior to receiving the complete submission.  Additionally, NDAs for fast track development programs ordinarily will be eligible for priority review, which implies an abbreviated review time of six months. 

"There are no FDA approved corticosteroid therapies for the induction treatment of Crohn's disease in the pediatric population," stated Christopher J. Schaber, PhD, President & Chief Executive Officer of Soligenix. "The FDA's action in granting fast track designation is an indication of SGX203's potential to address this debilitating, unmet medical need.  We look forward to working closely with the FDA to potentially expedite the development and NDA review process."

About Pediatric Crohn's Disease

Crohn's disease is an ongoing disorder that causes inflammation of the gastrointestinal (GI) tract. Crohn's disease can affect any area of the GI tract, from the mouth to the
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children
2. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
3. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
4. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
5. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
6. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
7. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
8. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
9. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
10. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
11. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Pharmaceutical Industry in China to 2020: An ... Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, ... This report tackles not only ... but also home grown companies and ...
(Date:7/28/2015)... Mass. , July 28, 2015  Alere Inc. ... diagnostics, today announced that it will release its financial ... The Company will host a conference call beginning at ... discuss these results and provide business updates. ... the Investor Relations section of Alere,s website, or accessed ...
(Date:7/28/2015)... HOUSTON, TX , July 28, 2015 /PRNewswire/ ... ) is pleased to announce that it has received final ... trading on the Toronto Stock Exchange (the "TSX"). The Company,s ... on Tuesday, July 28, 2015 under the trading symbol ,EPI,.  ... Venture Exchange. About ESSA Pharma Inc. ...
Breaking Medicine Technology:Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 3
... FRANCISCO, Calif., Nov. 27 Raven,biotechnologies, inc., a privately ... (MAbs) for cancer, today announced it,is continuing to enroll ... of its Phase 1/2a trial for patients with cancers ... RAAG12 is a glycotope (sugar structure) that is widely ...
... Kinex Pharmaceuticals LLC,announced today that their drug KX2-391 ... is entitled "A combined rising single-dose (RSD) and,rising ... tolerability,and pharmacokinetics of KX2-391 in patients with advanced ... belongs to an emerging,new family of targeted cancer ...
Cached Medicine Technology:Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 2Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 3First Patient Dosed with KX2-391 in Phase 1 Clinical Trial 2
(Date:7/28/2015)... Hills, CA (PRWEB) , ... July 28, 2015 , ... ... Chamber Therapy May Easy Fibromyalgia, Study Says " sheds light on a possible new ... a period of two months of regular HBOT sessions, at least five per week, ...
(Date:7/28/2015)... ... 2015 , ... Most employers have been using multi-tier prescription drug plans for ... a significant increase in the use of 4-tier plans, which typically cover the highest ... that is expected to continue, according to UBA. , UBA’s survey finds that, since ...
(Date:7/28/2015)... ... 28, 2015 , ... PeopleKeys today announced that their partner, ... EY Entrepreneur of the Year award. The award recognizes the important strides Burchianti ... innovative work they have done in incorporating new technology, processes, and procedures into ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Maryland Brain & ... – and, along with it, more service offerings, updated treatment techniques, and additional state-of-the ... for pain management and minimally invasive surgical treatment of brain and spine conditions. ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... to a number of publications, including Runner’s World Magazine, is plantar fasciitis ... this constant pain. , Designed by a professional athletic trainer, the Zensah ...
Breaking Medicine News(10 mins):Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2
... drilling, new energy technologies, science at the LHC, tests of gravity ... edge science will be featured in talks at this year,s April ... April 30 to May 3 at the Hyatt Hotel Orange County ... free of charge. Registration information can be found at the end ...
... be at increased risk of damage to the same brain ... by researchers at Washington University School of Medicine in St. ... that scientists have linked to neurological problems including Parkinson,s disease-like ... than 1 million workers who perform welding as a part ...
... the School of Public Health at the University of ... of depression may have long-term benefits. The data ... a longitudinal Canadian study, and showed depressed adults who ... depressed eight years later, compared to depressed adults who ...
... , WEDNESDAY, April 6 (HealthDay News) -- Long-term users ... damage, warns a new study. Brain scans showed an ... and a lower proportion of overall gray matter among long-term ... that people who use ecstasy can develop serious memory problems, ...
... THURSDAY, April 7 (HealthDay News) -- For American parents, doctors ... of children,s vaccines, a new study indicates. Researchers conducted ... and younger, and found that 76 percent said they trusted ... information about vaccine safety. Other sources trusted "a lot" ...
... (HealthDay News) -- A new report reveals that 98.8 percent ... to 64 with untreated alcohol abuse disorders don,t believe they ... nearly 6 million American adults with untreated alcohol dependence recognize ... to increase public awareness about adult problem drinking, how to ...
Cached Medicine News:Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 2Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 3Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 4Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 5Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 6Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 7Health News:Nuclear security, deep water drilling, black hole signal flares and more at 2011 APS annual meeting 8Health News:Welders may be at increased risk for brain damage 2Health News:Treatment for depression a long-term solution 2Health News:Long-Term Ecstasy Users at Risk for Brain Damage, Study Warns 2Health News:Doctors Most Trusted Source of Vaccine Information, Study Finds 2Health News:Only 1.2% of Alcohol Abusers Know They Need Help: Report 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: